What specific patient populations benefit the most from ritlecitinib treatment?Featuring Brittany Craiglow, MD | Assistant Professor Adjunct DermatologyYale School of MedicineNew Haven, CT | Published November 07, 2024Loading...Related CMEView allRelated MediaPowered by Polaris TM